ASCOMCER

What ASCOMCER does

ASCOMCER (Associação Feminina de Prevenção e Combate ao Câncer de Juiz de Fora) is a Brazilian nonprofit philanthropic oncology hospital founded in 1963 and headquartered in Juiz de Fora, Minas Gerais. The institution operates Hospital Maria José Baeta Reis, a 71-bed facility (62 beds allocated to SUS patients) with a 5-bed ICU, and serves approximately 5,000 patients per month drawn from Juiz de Fora and 94 surrounding cities in the Zona da Mata Mineira region. As the only specialized philanthropic oncology hospital in the region accredited to serve SUS (Sistema Único de Saúde) patients, ASCOMCER directs over 90% of its care to public-health-system patients and provides free cancer treatment as its core offering.

The hospital's service portfolio spans the full oncology continuum: chemotherapy and radiotherapy delivered via a state-of-the-art linear accelerator with 3D radiotherapy capabilities, high-complexity oncological and reconstructive surgeries, diagnostic imaging (mammography, ultrasound, X-ray, and laboratory pathology), and outpatient consultations in specialties such as Gynecology, Mastology, Urology, Nutrition, Speech Therapy, and Psychosocial Support. Support services — wig loans, artisanal breast prostheses, psychosocial groups, nutritional guidance, and smoking cessation programs — round out a multidisciplinary care model. In 2025, ASCOMCER performed 1,303 surgeries (including 984 oncological), administered 15,576 chemotherapy treatments, and delivered 6,190 radiotherapy treatments. Adjacent initiatives include the Ascomóvel mobile outreach unit for community prevention education, the Medical Residence Program launched in 2026, and partnerships with UFJF Faculty of Dentistry (oncology dental care) and Instituto Assistencial Plurividas (300 monthly preventive screening slots).

The business model is structured around three revenue streams. First, SUS reimbursement covers the vast majority of clinical services (~90% of patient volume) under Brazilian public-health contracting rules. Second, private health insurance (convênios) accounts for approximately 2% of patient volume. Third, philanthropic donations — monthly subscriptions at R$30, R$55, and R$130 tiers via PIX and credit card, one-time contributions, corporate donations, and proceeds from events such as the Corrida Solidária Outubro Rosa and Festival Solidário de Cervejas — fund medications, equipment, and infrastructure. A R$15 million capital allocation from the Government of Minas Gerais is funding a new linear accelerator (announced 2024, finalized April 2026) intended to be the most modern radiotherapy equipment in the state dedicated to SUS care. ASCOMCER is governed by a Board of Directors, Fiscal Council, and Executive Board led by Director President Márcio Aurélio Aquino de Oliveira, with no parent company, subsidiaries, or institutional equity ownership identified.

Name

ASCOMCER

Legal name

Associação Feminina de Prevenção e Combate ao Câncer de Juiz de Fora

Website

https://ascomcer.org.br

Company type

Private

Founded year

1963

Operating status

Operating

Headcount range

101–250 employees

Short description

ASCOMCER is a nonprofit philanthropic oncology hospital in Juiz de Fora, Brazil, serving ~5,000 SUS and private patients monthly from 95 cities via 71 beds, chemotherapy, radiotherapy, surgery, and diagnostic services, funded by public reimbursement, donations, and fundraising events.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology treatment services
• Cancer care hospital
• Chemotherapy radiotherapy
• Diagnostic imaging services
• Charitable healthcare

Headquarters

HQ city

Juiz De Fora

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Others, Marketing or Sales, Technology or R&D

Revenue model

1. SUS (Public Health System) Reimbursement: The majority of ASCOMCER's services are provided through the Brazilian public health system (SUS), with over 90% of patient care directed to SUS patients. The institution receives government reimbursement for services rendered.
2. Health Insurance (Convênios): ASCOMCER also serves patients with private health insurance plans, representing approximately 2% of patient volume.
3. Donations and Charitable Contributions: As a non-profit philanthropic institution, ASCOMCER relies heavily on donations from individuals, companies, and organizations to fund medications, equipment, and infrastructure. Monthly donation options of R$30, R$55, R$130 are available, along with PIX and one-time donation options.
4. Events and Fundraising: ASCOMCER organizes fundraising events including Corrida Solidária Outubro Rosa, Arraiá Beneficente, Feijoada Beneficente, and Festival Solidário de Cervejas to raise additional funds.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

ASCOMCER is a nonprofit philanthropic oncology hospital that provides comprehensive cancer care — prevention, diagnosis, chemotherapy, radiotherapy, oncological/reconstructive surgery, and outpatient consultations — to patients in Juiz de Fora and 94 surrounding cities in Minas Gerais, Brazil. Over 90% of care is delivered free of charge to SUS (public health system) patients, supplemented by psychosocial, nutritional, and patient-support services. Operations are sustained by SUS reimbursements, private health insurance (convênios), and a robust donations and fundraising program.

Product overview

ASCOMCER (Associação Feminina de Prevenção e Combate ao Câncer de Juiz de Fora) is a nonprofit oncology hospital offering comprehensive cancer treatment services. The institution operates as a unified hospital system with core services including Chemotherapy (Quimioterapia), Radiotherapy (Radioterapia), Medical Consultations, Diagnostic Exams (mammography, ultrasound, X-ray, laboratory), and Surgeries with Hospitalization. The hospital provides 71 beds with 62 dedicated to SUS (public health system) patients, representing over 90% of its 5,000+ monthly patient visits. Support services include patient assistance programs (wig loans, handmade prostheses), psychosocial support groups, nutritional guidance, and smoking cessation programs. The institution also operates a Medical Residence Program for physician training and conducts annual awareness events like the October Rose Solidarity Race. As a philanthropic institution over 60 years old, ASCOMCER relies on charitable donations to supplement public health funding for medication purchases, equipment maintenance, and infrastructure support.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy (Quimioterapia) Outpatient chemotherapy treatment using medications administered via intramuscular, oral, subcutaneous, or intrathecal routes to destroy or block cancer cell growth, accompanied by multidisciplinary supportive care. Available to SUS patients (over 90% of volume) and convênio patients.
• Radiotherapy (Radioterapia) Cancer treatment using ionizing radiation delivered via a linear accelerator with precise radiation-dose control, 3D conformal radiotherapy, multileaf collimator for healthy-tissue protection, and multiple electron/photon beam energies for treating deep tumors. A new state-of-the-art linear accelerator is being added in 2026.
• Diagnostic Exams (Exames) Diagnostic imaging and laboratory services including mammography, preventive (cervical) exams, ultrasound, X-ray, and clinical pathology tests for SUS and private patients.
• Medical Consultations (Consultas) Outpatient consultations in specialties including Gynecology, Mastology, Urology, Speech Therapy, Nutrition, and Psychosocial Support for SUS and private patients.
• Surgeries and Hospitalization (Cirurgias e Internação) Surgical procedures including high-complexity oncological, aesthetic, and reconstructive surgeries delivered by a multidisciplinary team. Inpatient capacity totals 71 beds with 5 ICU beds; 1,303 surgeries (984 oncological) were performed in 2025.
• Preventive Exams Program (Programa de Exames Preventivos) Partnership program with Instituto Assistencial Plurividas providing 300 monthly slots for free gynecological preventive exams including breast and cervical cancer screening for women in the region.
• Patient Support Services (Espaço do Paciente) Comprehensive patient support services including wig loans, handmade breast prostheses for mastectomized patients, psychosocial support groups, nutritional guidance, and smoking cessation programs.
• Medical Residence Program (Residência Médica) Medical training program offering physician residencies in Clinical Medicine, Anesthesiology, and General Surgery for medical graduates.

Quantifiable outcome

• Over 90% of patient care directed to SUS patients, serving approximately 5,000 patients monthly from 95 cities
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Farmácia IndianaminorOthers · 11 March 2026Donated more than 10,000 units of geriatric diapers to support oncology patients, providing dignity and comfort to those undergoing cancer treatment.
• Associação das Cervejarias da Zona da Mata Mineira (Unicerva ZM)minorGTM or Marketing Partner · 1 August 2025Partner in the 4th Solidary Beer Festival, with 12 craft breweries participating. Event raised funds for ASCOMCER's oncology services while promoting local craft beer culture.
• Instituto Assistencial PlurividascoreStrategic or Co-development Partner · 1 January 2025Partnership to provide 300 monthly slots for free gynecological preventive exams (mammography and cervical cancer screening). More than 500 women have been served since the campaign began. The initiative aims to expand access to cancer prevention for women in the region.
• Government of Minas GeraiscoreOthers · 22 August 2024The Vice-Governor of Minas Gerais, Mateus Simões, announced R$15 million in funding for the acquisition of a new linear accelerator - the most modern radiotherapy equipment in the state for SUS patients. This positions Juiz de Fora at the forefront of oncology technology.
• Deputado Estadual Noraldino JúniorcoreOthers · 1 August 2024Supported the government funding announcement of R$15 million for the new linear accelerator acquisition, advocating for improved oncology care in the region.
• LobackminorOthers · 28 November 2023Donated 150 kits containing bras and artisanal breast prostheses to help mastectomized patients regain self-esteem after breast cancer surgery. Loback is a lingerie company from Mar de Espanha.
• Igreja de Jesus Cristo dos Santos dos Últimos DiascoreOthers · 15 September 2023Donated a 365-liter barrier autoclave worth R$ 223,668 through their humanitarian projects. The equipment replaced an aging unit that had been in use for two decades and is essential for sterilizing surgical materials.
• Universidade Federal de Juiz de Fora (UFJF) - Faculty of DentistrycoreStrategic or Co-development Partner · 28 August 2023Partnership to provide dental care services to oncology patients, addressing oral health issues that can arise from chemotherapy, radiotherapy, and immunotherapy treatments. Several volunteer dentists participate.
• Rotary Club de Juiz de Fora São MateuscoreOthers · 29 March 2022Donated medical equipment including surgical instruments, breast ramps, and chiller through a global subsidy project worth R$169,000, sponsored by the Rotary Foundation of Rotary International in partnership with Rotary Club of Juiz de Fora São Mateus and Rotary Club of New York.
• SuperlarminorOthers · 17 September 2019Donated R$ 22,623.25 from the 'Comprou, Ajudou!' campaign, with proceeds from selling decorative signs used to purchase chemotherapy medications.
• Colégio dos Jesuítas de Juiz de ForaminorOthers · 27 August 2019Donated R$ 29,310 raised through their traditional July festival, designated for purchasing chemotherapy medications.
• HavanminorOthers · 12 August 2019Through the 'Troco Solidário' campaign, donated R$ 57,000 from customer round-up donations. Partnership began in 2015, with funds used for chemotherapy and radiotherapy medications.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• A.C.Camargo Cancer Center: One of Brazil's leading oncology specialty hospitals based in São Paulo, offering the full continuum of cancer care (prevention, diagnosis, treatment, research). Comparable as an oncology specialty hospital with multi-modality service delivery, though at substantially greater scale and with broader geographic reach than ASCOMCER.
• Hospital Sírio-Libanês - Oncology Center: Premium private hospital in São Paulo with a renowned oncology center providing advanced cancer treatment including precision radiotherapy and complex surgical oncology. Comparable as a high-end oncology specialty provider with full multi-modality service, though private/convenio focused rather than SUS-dependent.
• Oncoclínicas Group: Largest private oncology network in Latin America with clinics and hospitals across Brazil offering chemotherapy, radiotherapy, and specialized oncology care. Comparable in service lines (chemo, radiation, surgical oncology) but operates a for-profit, multi-state private model versus ASCOMCER's regional nonprofit/SUS focus.
• Instituto Nacional de Câncer (INCA): Brazil's federal public cancer institute providing oncology treatment, research, and policy leadership. Comparable as a SUS-aligned oncology hospital network serving public patients, though INCA operates at a national scale versus ASCOMCER's regional focus.
• Hospital Israelita Albert Einstein - Oncology: Top-tier private hospital in São Paulo with a dedicated oncology center offering advanced radiotherapy, chemotherapy, and surgical oncology. Comparable in advanced cancer treatment capability (including linear accelerator) and multi-modality service, though primarily serves private-pay patients rather than SUS.
• Fundação Pio XII / Hospital de Câncer de Barretos: Largest philanthropic oncology hospital in Brazil, headquartered in Barretos, São Paulo. Directly comparable as a nonprofit, SUS-funded oncology hospital providing comprehensive cancer treatment with strong donation-based funding — ASCOMCER operates as a smaller, regionally-focused version of this model.

Direct peers

• Hospital do Câncer de Muriaé / Fundação Cristiano Varella: Philanthropic oncology hospital in Muriaé, Minas Gerais serving SUS patients in the Zona da Mata region. Highly comparable to ASCOMCER as a regional, donation-funded cancer hospital in the same Brazilian state with similar service mix (chemo, radiation, surgery) and patient base.
• UOPECCAN (Hospital do Câncer de Cascavel): Philanthropic oncology hospital in Paraná serving SUS patients across western Paraná with comprehensive cancer services. Directly comparable to ASCOMCER as a regional, donation-supported SUS-focused oncology specialty hospital of similar scale and operating philosophy.
• Hospital do Câncer de Londrina / Hospital Norte Paranaense: Regional philanthropic oncology hospital in Londrina, Paraná providing SUS-funded cancer treatment with donation-supported operations. Comparable to ASCOMCER as a state-level nonprofit oncology hospital of similar size and SUS/donation revenue mix.

Regional players

• Santa Casa de Misericórdia de Juiz de Fora: Largest general hospital in Juiz de Fora offering multi-specialty inpatient and outpatient services including some oncology. Comparable as a SUS-dependent philanthropic hospital in the same city and overlapping patient catchment, though not specialized exclusively in oncology like ASCOMCER.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/ascomcer
• Facebookfacebook.com/hospital.ascomcer
• LinkedInlinkedin.com/company/hsptascomcer

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASCOMCER